Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 16, Supplement N, December 1995   [Index by Author] 


Down List of contributors
Down Foreword
Down Molecular and Structural Aspects of Hypertrophy
Down Post-Infarction Myocardial Remodelling
Down Neurohormonal Activation and Heart Failure-Role of ACE Inhibition
Down Neurohormonal Modulation in Heart Failure-Beyond ACE Inhibition
Down Aldosterone Receptor Blockade in Heart Failure Patients-Revisited
Down Selected Abstracts


[Search ALL Issues]


Front Matter (PDF) | Back Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

List of contributors Back

List of contributors
Eur Heart J 1995 16: iii; doi:10.1093/eurheartj/16.suppl_N.iii [PDF] [Request Permissions]  

Foreword Back

W. J. Remme
Foreword
Eur Heart J 1995 16: 1-2; doi:10.1093/eurheartj/16.suppl_N.1 [PDF] [Request Permissions]  

Molecular and Structural Aspects of Hypertrophy Back

K. R. Boheler and A. F. M. Moorman
Molecular aspects of myocardial differentiation
Eur Heart J 1995 16: 3-7; doi:10.1093/eurheartj/16.suppl_N.3 [Abstract] [PDF] [Request Permissions]  

L. Neyses and T. Pelzer
The biological cascade leading to cardiac hypertrophy
Eur Heart J 1995 16: 8-11; doi:10.1093/eurheartj/16.suppl_N.8 [Abstract] [PDF] [Request Permissions]  

K. T. Weber, Y. Sun, and S. E. Campbell
Structural remodelling of the heart by fibrous tissue: Role of circulating hormones and locally produced peptides
Eur Heart J 1995 16: 12-18; doi:10.1093/eurheartj/16.suppl_N.12 [Abstract] [PDF] [Request Permissions]  

M. O. Boluyt, O. H. L. Bing, and E. G. Lakatta
The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure
Eur Heart J 1995 16: 19-30; doi:10.1093/eurheartj/16.suppl_N.19 [Abstract] [PDF] [Request Permissions]  

Post-Infarction Myocardial Remodelling Back

G. S. Francis and C. Chu
Post-infarction myocardial remodelling: Why does it happen?
Eur Heart J 1995 16: 31-36; doi:10.1093/eurheartj/16.suppl_N.31 [Abstract] [PDF] [Request Permissions]  

P. Anversa, K. Reiss, J. Kajstura, W. Cheng, P. Li, E. H Sonnenblick, and G. Olivetti
Myocardial infarction and the myocyte IGF1 autocrine system
Eur Heart J 1995 16: 37-45; doi:10.1093/eurheartj/16.suppl_N.37 [Abstract] [PDF] [Request Permissions]  

J. F. M. Smits, R. C. J. J. Passier, H. J. M. G. Nelissen-Vrancken, J. P. M. Cleutjens, M. C. Kuizinga, and M. J. A. P. Daemen
Does ACE inhibition limit structural changes in the heart following myocardial infarction?
Eur Heart J 1995 16: 46-51; doi:10.1093/eurheartj/16.suppl_N.46 [Abstract] [PDF] [Request Permissions]  

Neurohormonal Activation and Heart Failure-Role of ACE Inhibition Back

D. Elsner
Changes in neurohumoral systems during the development of congestive heart failure: Impact on cardiovascular and renal function
Eur Heart J 1995 16: 52-58; doi:10.1093/eurheartj/16.suppl_N.52 [Abstract] [PDF] [Request Permissions]  

M. A. Konstam
Angiotensin converting enzyme inhibition, in asymptomatic left ventricular systolic dysfunction and early heart failure
Eur Heart J 1995 16: 59-64; doi:10.1093/eurheartj/16.suppl_N.59 [Abstract] [PDF] [Request Permissions]  

A. Sigurdsson and K. Swedberg
Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use
Eur Heart J 1995 16: 65-72; doi:10.1093/eurheartj/16.suppl_N.65 [Abstract] [PDF] [Request Permissions]  

Neurohormonal Modulation in Heart Failure-Beyond ACE Inhibition Back

W. J. Remme
Neurohormonal modulation in heart failure: ACE inhibition and beyond
Eur Heart J 1995 16: 73-78; doi:10.1093/eurheartj/16.suppl_N.73 [Abstract] [PDF] [Request Permissions]  

H. Urata, H. Nishimura, and D. Ganten
Mechanisms of angiotensin H formation in humans
Eur Heart J 1995 16: 79-85; doi:10.1093/eurheartj/16.suppl_N.79 [Abstract] [PDF] [Request Permissions]  

V. Regitz-Zagrosek, M. Neuss, and E. Fleck
Effects of angiotensin receptor antagonists in heart failure: Clinical and experimental aspects
Eur Heart J 1995 16: 86-91; doi:10.1093/eurheartj/16.suppl_N.86 [Abstract] [PDF] [Request Permissions]  

Aldosterone Receptor Blockade in Heart Failure Patients-Revisited Back

J. P. Bonvalet, N. Alfaidy, N. Farman, and M. Lombès
Aldosterone: intracellular receptors in human heart
Eur Heart J 1995 16: 92-97; doi:10.1093/eurheartj/16.suppl_N.92 [Abstract] [PDF] [Request Permissions]  

F. Zannad
Aldosterone and heart failure
Eur Heart J 1995 16: 98-102; doi:10.1093/eurheartj/16.suppl_N.98 [Abstract] [PDF] [Request Permissions]  

A. D. Struthers
Aldosterone escape during ACE inhibitor therapy in chronic heart failure
Eur Heart J 1995 16: 103-106; doi:10.1093/eurheartj/16.suppl_N.103 [Abstract] [PDF] [Request Permissions]  

B. Pitt
ACE inhibitor co-therapy in patients with heart failure: Rationale for the Randomized Aldactone Evaluation Study (RALES)
Eur Heart J 1995 16: 107-110; doi:10.1093/eurheartj/16.suppl_N.107 [Abstract] [PDF] [Request Permissions]  

Selected Abstracts Back

Selected Abstracts
Eur Heart J 1995 16: 113-130; doi:10.1093/eurheartj/16.suppl_N.113 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.